Clarity Pharmaceuticals Ltd (ASX:CU6)
3.500
+0.070 (2.04%)
Feb 21, 2025, 4:10 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1.12 billion as of February 21, 2025. Its market cap has increased by 61.67% in one year.
Market Cap
1.12B
Enterprise Value
987.79M
Revenue
11.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.50
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.12B, an increase of 192.63%. That is a compound annual growth rate of 35.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 1.12B | -15.96% |
Dec 31, 2024 | 1.34B | 168.49% |
Dec 29, 2023 | 498.26M | 93.82% |
Dec 30, 2022 | 257.07M | 35.63% |
Dec 31, 2021 | 189.54M | -50.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 125.25B |
Pro Medicus | 29.87B |
Cochlear | 17.59B |
Sonic Healthcare | 13.15B |
Telix Pharmaceuticals | 10.15B |
Ramsay Health Care | 7.87B |
Ansell | 5.19B |
Mesoblast | 3.38B |